Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites

NCT07920575 is registered in ClinicalTrials.gov with Union Health System as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07920575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites
Lead sponsor
Union Health System
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
December 31, 2028
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgical procedures, coronary artery disease, heart valve diseases

Arms

As registered; 1 arm.

  • Adult cardiac surgery patients Risk score calculation

    Consecutive patients 18 years or older undergoing cardiac surgery at a participating site. Risk scores are calculated for research only and do not change care

Primary endpoints

Registered primary outcome measures; 2 primary.

  • 30 day MACCE 30 days after surgery

    Occurrence within 30 days after surgery of any component of a composite of all-cause mortality, permanent stroke, renal failure (per the current STS Adult Cardiac Surgery Database definition) and prolonged ventilation (more than 24 hours). STS standard definitions are applied at all sites. Used to assess discrimination and calibration of UCSRS, STS-PROM and EuroSCORE II.

  • 30 day all cause mortality 30 day after surgery

    Death from any cause within 30 days of the index procedure, or in-hospital death after day 30 where the patient has remained continuously admitted since the index procedure. Used to assess calibration (observed/expected ratio, calibration slope and intercept) of UCSRS, STS-PROM and EuroSCORE II.

Similar trials

Same condition (Frailty) and phase, most recent start first.